Endo International plc

306 articles about Endo International plc

• Endo International Announces Presentation At Barclays Global Healthcare Conference

  3/10/2016

• Endo International Provides Informational Frequently Asked Questions & Answers

  3/2/2016

• In Otherwise Strong Year, Endo International Shutters Astora Women’s Health Unit Over Ongoing Litigation Risk

  3/1/2016

• Endo International Reports Fourth Quarter And Full Year 2015 Financial Results

  2/29/2016

• Endo International Announces Launch of BELBUCA (Buprenorphine) Buccal Film for Chronic Pain Management

  2/22/2016

• Endo International Announces Initiation Of Phase 2B Clinical Trial Of Collagenase Clostridium Histolyticum In Cellulite

  2/17/2016

• Endo International Announces The Qualitest Scholarship Program

  2/1/2016

• Endo International Kills Deals with Auxilium Pharma and Acerus

  12/31/2015

• Embattled Acerus Loses U.S. Distribution Deal for Natesto With Endo International

  12/31/2015

• Endo International Announces Appearances At Upcoming Conferences

  12/21/2015

• Endo International Announces Extension Of U.S. Rights For Voltaren Gel

  12/14/2015

• Endo International Announces Conditional Redemption Of All $400,000,000 Aggregate Principal Amount Outstanding Of The Two Series Of 7.00% Senior Notes Due 2020

  11/23/2015

• Endo International Provides Informational Frequently Asked Questions & Answers

  11/9/2015

• BioSpecifics Technologies Corporation Announces Partner Endo International Exercises Early Opt-In For XIAFLEX For Two New Indications

  11/6/2015

• Endo International To Announce Third Quarter 2015 Financial Results On November 5, 2015

  10/22/2015

• Endo International Provides Update On Use Of Specialty Pharmacies

  10/22/2015

• Endo International Completes Acquisition Of Broad Portfolio Of Branded And Generic Products From Aspen Holdings

  10/2/2015

• Endo International Completes Acquisition Of Par Pharmaceutical Companies And Provides Financial Guidance

  9/28/2015

• ACETO Subsidiary, Rising Pharmaceuticals, Inc, Acquires Three FDA-Approved ANDAs From Endo International

  9/28/2015

• Endo International Announces Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Par Pharma

  9/25/2015